Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy

被引：0
|
作者：
Beatriz Alvarado-Castillo
Francisco J. Santa Cruz-Pavlovich
Celia Gonzalez-Castillo
Isaac Alejandro Vidal-Paredes
Leonel Garcia-Benavides
Maria Elena Rosales-Gradilla
Jose Navarro-Partida
机构：
[1] Instituto Mexicano del Seguro Social,
[2] Centro Medico Nacional de Occidente,undefined
[3] Tecnologico de Monterrey,undefined
[4] Escuela de Medicina y Ciencias de la Salud,undefined
[5] Universidad de Guadalajara,undefined
[6] Centro Universitario de Ciencias de la Salud,undefined
来源：
BMC Ophthalmology | / 23卷
关键词：
Efficacy; Eye drops; Interferon alpha 2b; Mitomycin C; Ocular surface squamous neoplasia; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and safety of long-term postpartum antiviral therapy in hepatitis B virus-infected mothers receiving prophylactic tenofovir disoproxil fumarate treatment
    Feng, Yali
    Yao, Naijuan
    Shi, Lei
    Zhu, Yage
    Liu, Jinfeng
    He, Yingli
    Zhao, Yingren
    Chen, Tianyan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (02) : 212 - 218
  • [32] Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study
    Trevisan, Caterina
    Raparelli, Valeria
    Malara, Alba
    Abbatecola, Angela Marie
    Noale, Marianna
    Palmieri, Annapina
    Fedele, Giorgio
    Di Lonardo, Anna
    Leone, Pasqualina
    Schiavoni, Ilaria
    Stefanelli, Paola
    Volpato, Stefano
    Incalzi, Raffaele Antonelli
    Onder, Graziano
    INTERNAL AND EMERGENCY MEDICINE, 2023, 18 (05) : 1337 - 1347
  • [33] Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study
    Caterina Trevisan
    Valeria Raparelli
    Alba Malara
    Angela Marie Abbatecola
    Marianna Noale
    Annapina Palmieri
    Giorgio Fedele
    Anna Di Lonardo
    Pasqualina Leone
    Ilaria Schiavoni
    Paola Stefanelli
    Stefano Volpato
    Raffaele Antonelli Incalzi
    Graziano Onder
    Internal and Emergency Medicine, 2023, 18 : 1337 - 1347
  • [34] SAFETY AND EFFICACY OF FILGOTINIB: AN UPDATE FROM THE DARWIN 3 PHASE 2 LONG-TERM EXTENSION WITH A MAXIMUM OF 8.2 YEARS OF EXPOSURE
    Westhovens, R.
    Alten, R.
    Dagna, L.
    Kavanaugh, A.
    Winthrop, K.
    Barry, J.
    Besuyen, R.
    Corallo, C.
    De Vries, D.
    Martin, N.
    Watson, C.
    Genovese, M.
    Spindler, A.
    Stanislavchuk, M.
    Greenwald, M.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 712 - 713
  • [35] Long-term efficacy, safety, and cumulative retention rate of antitumor necrosis factor-alpha treatment for patients with Behcet's uveitis: A systematic review and meta-analysis
    Guan, Xin
    Zhao, Zerui
    Xin, Miaomiao
    Xia, Guangtao
    Yang, Qingrui
    Fu, Min
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (02)
  • [36] Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study
    Ochs-Ross, Rachel
    Wajs, Ewa
    Daly, EllaJ.
    Zhang, Yun
    Lane, Rosanne
    Lim, Pilar
    Drevets, Wayne C.
    Steffens, David C.
    Sanacora, Gerard
    Jamieson, Carol
    Hough, David
    Manji, Husseini
    Singh, Jaskaran B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (05) : 541 - 556
  • [37] Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study
    Ken Yoshikawa
    Akira Tsuchiya
    Tomoyuki Kido
    Tomohiro Ota
    Keiko Ikeda
    Mika Iwakura
    Yoshikazu Maeda
    Shinichiroh Maekawa
    Advances in Therapy, 2020, 37 : 2442 - 2459
  • [38] Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study
    Yoshikawa, Ken
    Tsuchiya, Akira
    Kido, Tomoyuki
    Ota, Tomohiro
    Ikeda, Keiko
    Iwakura, Mika
    Maeda, Yoshikazu
    Maekawa, Shinichiroh
    ADVANCES IN THERAPY, 2020, 37 (05) : 2442 - 2459
  • [39] Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
    Papp, Kim A.
    Krueger, James G.
    Feldman, Steven R.
    Langley, Richard G.
    Thaci, Diamant
    Torii, Hideshi
    Tyring, Stephen
    Wolk, Robert
    Gardner, Annie
    Mebus, Charles
    Tan, Huaming
    Luo, Yingchun
    Gupta, Pankaj
    Mallbris, Lotus
    Tatulych, Svitlana
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : 841 - 850
  • [40] Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
    Blauvelt, Andrew
    Langley, Richard G.
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Beissert, Stefan
    Wollenberg, Andreas
    Herranz, Pedro
    Pink, Andrew E.
    Peris, Ketty
    Fangel, Stine
    Gjerum, Le
    Corriveau, Joshua
    Saeki, Hidehisa
    Warren, Richard B.
    Simpson, Eric
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) : 815 - 824
12345